NCT00047307
- Conditions
- Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Stage IV Pancreatic Cancer
Explore clinical trials studying Stage IV Pancreatic Cancer. Study availability and eligibility vary by location and protocol.
70 public trials
1 recruiting study
Stage IV Pancreatic Cancer trial results
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
- Conditions
- Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT00028834
- Conditions
- Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Completed
UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
NCT00039403
- Conditions
- Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00075647
- Conditions
- Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00030498
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
Active, Not Recruiting
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
NCT02495896
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +39 more
- Locations
-
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
Active, Not Recruiting
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
NCT03682289
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +43 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Active, Not Recruiting
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
NCT03368963
- Conditions
- Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Neoplasms, +28 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States